Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-10-14

FDA Approved: FINGOLIMOD — Original Application (Zydus Lifesciences Limited)

View source ↗

Summary

The FDA approved Fingolimod from Zydus Lifesciences Limited as an Original Application for the treatment of relapsing forms of multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fingolimod (fingolimod)

Snippet

ORIG AP for FINGOLIMOD (FINGOLIMOD)